m6A RNA Methylation Regulators Elicit Malignant Progression and Predict Clinical Outcome in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and N6-methyladenosine (m6A) is a predominant internal modification of RNA in various cancers. We obtained the expression profiles of m6A-related genes for HCC patients from the International Cancer Genome Consortiu...
Main Authors: | Wenli Li, Jun Liu, Zhanzhong Ma, Xiaofeng Zhai, Binbin Cheng, Hetong Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2021/8859590 |
Similar Items
-
Multiple m6A RNA methylation modulators promote the malignant progression of hepatocellular carcinoma and affect its clinical prognosis
by: Nanfang Qu, et al.
Published: (2020-02-01) -
The Effect of m6A Methylation Regulatory Factors on the Malignant Progression and Clinical Prognosis of Hepatocellular Carcinoma
by: Zhongwei Zhao, et al.
Published: (2020-08-01) -
Effect of m6A RNA Methylation Regulators on Malignant Progression and Prognosis in Renal Clear Cell Carcinoma
by: Jiawu Wang, et al.
Published: (2020-01-01) -
Identification of key genes and long non-coding RNA associated ceRNA networks in hepatocellular carcinoma
by: Jun Liu, et al.
Published: (2019-11-01) -
Prognostic Power of a Chaperonin Containing TCP-1 Subunit Genes Panel for Hepatocellular Carcinoma
by: Wenli Li, et al.
Published: (2021-04-01)